Gilead Sciences, Inc.
LONG-ACTING FORMULATIONS OF TENOFOVIR ALAFENAMIDE
Last updated:
Abstract:
The present disclosure provides long-acting formulations of tenofovir alafenamide, methods of making the same and methods of using the same.
Status:
Application
Type:
Utility
Filling date:
17 Jul 2020
Issue date:
18 Aug 2022